MedTrace Logo

N-Care Project: Enhancing Asian-Pacific Collaboration

NCT06821386 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 70

Last updated 2025-02-20

No results posted yet for this study

Summary

Through Asian-Pacific multinational collaboration, we aim to utilize third-generation genome sequencing to rapidly diagnose genetic diseases in critically ill infants and young children, achieving the goal of early diagnosis for targeted treatment.

Conditions

  • Whole Genome Sequencing
  • Genetic Disease
  • Critical Care, Intensive Care
  • Nanopore Sequencing

Interventions

DIAGNOSTIC_TEST

Genetic study with nanopore sequencing

The study targets critically ill children under 18 months of age, employing third-generation genome sequencing technology to complete long-read sequencing within 8-11 days, analyzing single nucleotide variants, small insertions/deletions, and structural variations. Through this research, we aim to enhance diagnostic accuracy, enabling ICUs to provide personalized and precision care and treatment based on genetic information, thereby ensuring a greater level of health security for these children. We only draw 3-5cc whole blood once for exam.

Sponsors & Collaborators

  • National Taiwan University Hospital

    lead OTHER

Eligibility

Max Age
18 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-02-17
Primary Completion
2025-12-31
Completion
2032-12-31

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06821386 on ClinicalTrials.gov